Document is current
Any future updates will be listed below
-
Authors
Farini, Andrea https://orcid.org/0000-0002-8514-4921
Molinaro, Monica
Mostosi, Debora
Camera, Mattia
Russo, Michele
Leonetti, Emma
Meregalli, Mirella
Prandi, Lucia
Liaci, Carla
Ghigo, Alessandra
Hirsch, Emilio
Merlo, Giorgio
Torrente, Yvan https://orcid.org/0000-0002-2705-3984
-
Funding
Funding for this research was provided by:
Università degli Studi di Milano
- License Information
-
More Information
Article History
Received: 6 May 2025
Revised: 8 September 2025
Accepted: 16 October 2025
First Online: 30 December 2025
Declarations
:
: All authors commented on previous versions of the manuscript and approved the final manuscript. All authors have consented for publication of this manuscript.
: AG is co-founder and shareholder of Kither Biotech, a pharmaceutical company focused on the development of PI3K inhibitors for airway diseases not in conflict with the content of this paper. All the other authors have no relevant financial or non-financial interests to disclose.
